Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02915523
Title Phase 1b/2 Study of Avelumab With or Without Entinostat in Patients With Advanced Epithelial Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Syndax Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
H. Lee Moffitt Cancer Center and Research Tampa Florida 33612 United States Details
Florida Cancer Specialist East Region (SCRI Affiliate) West Palm Beach Florida 33401 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Greater Baltimore Medical Center Baltimore Maryland 21204 United States Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Baltimore Maryland 21287 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
HCA Midwest Health (SCRI Affiliate) Kansas City Missouri 64131 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19107 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37204 United States Details
University of Virginia Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field